JP7469317B2 - ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞 - Google Patents

ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞 Download PDF

Info

Publication number
JP7469317B2
JP7469317B2 JP2021543274A JP2021543274A JP7469317B2 JP 7469317 B2 JP7469317 B2 JP 7469317B2 JP 2021543274 A JP2021543274 A JP 2021543274A JP 2021543274 A JP2021543274 A JP 2021543274A JP 7469317 B2 JP7469317 B2 JP 7469317B2
Authority
JP
Japan
Prior art keywords
cells
pluripotent stem
cell
stem cells
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021543274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520722A (ja
JP2022520722A5 (cg-RX-API-DMAC7.html
Inventor
憲人 大西
ネイサン シー． マンレイ
クレイグ アール． ハルバーシュタット
エリック エム． ウィットリー
Original Assignee
アステリアス バイオセラピューティクス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アステリアス バイオセラピューティクス インコーポレイテッド filed Critical アステリアス バイオセラピューティクス インコーポレイテッド
Publication of JP2022520722A publication Critical patent/JP2022520722A/ja
Publication of JP2022520722A5 publication Critical patent/JP2022520722A5/ja
Priority to JP2024060751A priority Critical patent/JP2024096785A/ja
Application granted granted Critical
Publication of JP7469317B2 publication Critical patent/JP7469317B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
JP2021543274A 2019-01-23 2020-01-23 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞 Active JP7469317B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024060751A JP2024096785A (ja) 2019-01-23 2024-04-04 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962796077P 2019-01-23 2019-01-23
US62/796,077 2019-01-23
PCT/US2020/014834 WO2020154533A1 (en) 2019-01-23 2020-01-23 Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024060751A Division JP2024096785A (ja) 2019-01-23 2024-04-04 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞

Publications (3)

Publication Number Publication Date
JP2022520722A JP2022520722A (ja) 2022-04-01
JP2022520722A5 JP2022520722A5 (cg-RX-API-DMAC7.html) 2024-02-06
JP7469317B2 true JP7469317B2 (ja) 2024-04-16

Family

ID=71609769

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021543274A Active JP7469317B2 (ja) 2019-01-23 2020-01-23 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞
JP2024060751A Pending JP2024096785A (ja) 2019-01-23 2024-04-04 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024060751A Pending JP2024096785A (ja) 2019-01-23 2024-04-04 ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞

Country Status (9)

Country Link
US (3) US11603518B2 (cg-RX-API-DMAC7.html)
EP (1) EP3914264A4 (cg-RX-API-DMAC7.html)
JP (2) JP7469317B2 (cg-RX-API-DMAC7.html)
KR (2) KR102910994B1 (cg-RX-API-DMAC7.html)
CN (2) CN120060141A (cg-RX-API-DMAC7.html)
AU (2) AU2020210757B2 (cg-RX-API-DMAC7.html)
CA (1) CA3127213A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202107732XA (cg-RX-API-DMAC7.html)
WO (1) WO2020154533A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3019514A1 (en) 2016-03-30 2017-10-05 Asterias Biotherapeutics, Inc. Oligodendrocyte progenitor cell compositions
AU2019342741B2 (en) 2018-09-19 2025-12-11 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture
AU2020210757B2 (en) 2019-01-23 2026-04-16 Asterias Biotherapeutics, Inc. Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
US20240082311A1 (en) * 2021-01-28 2024-03-14 Asterias Biotherapeutics, Inc. Compositions and methods for treating spinal cord injuries
KR20230154071A (ko) * 2021-03-10 2023-11-07 리니지 셀 테라퓨틱스, 인크. 희소돌기아교세포 전구 세포의 생성 방법 및 이의 용도
JP2025504662A (ja) * 2022-01-28 2025-02-14 アステリアス バイオセラピューティクス インコーポレイテッド 脊髄損傷の治療のための組成物及び方法
CA3256595A1 (en) * 2022-05-24 2023-11-30 Bluerock Therapeutics Lp METHODS FOR MANUFACTURED OLIGODENDROCYTE PROGENITOR CELLS
WO2025049991A1 (en) * 2023-08-31 2025-03-06 The Board Of Trustees Of The Leland Stanford Junior University Compositions comprising neurons and methods of using the same
KR20250094234A (ko) * 2023-12-18 2025-06-25 ㈜바이오솔빅스 콘케이브와 진탕배양 기법으로 형성된 전분화능 줄기세포 유래 신경세포 제조방법 및 이에 의해 제조된 3d 신경 오가노이드를 통한 약물 독성 평가방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006517084A (ja) 2002-07-16 2006-07-20 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 胚性幹細胞の分化を誘導する方法及びその用途
JP2010536357A (ja) 2007-08-20 2010-12-02 ユニヴァルシテ リブレ デ ブリュッセル 多能性幹細胞からのニューロン細胞の生成
JP2017511153A (ja) 2014-03-21 2017-04-20 セルラー ダイナミクス インターナショナル， インコーポレイテッド 中脳ドーパミン作動性ニューロンの生産およびその使用方法
WO2017132596A1 (en) 2016-01-27 2017-08-03 Memorial Sloan-Kettering Cancer Center Differentiation of cortical neurons from human pluripotent stem cells
WO2020061371A2 (en) 2018-09-19 2020-03-26 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048001A1 (en) * 1997-04-24 1998-10-29 California Institute Of Technology Methods for differentiating neural stem cells
US6361996B1 (en) 1997-05-07 2002-03-26 University Of Utah Research Foundation Neuroepithelial stem cells and glial-restricted intermediate precursors
WO1999020740A2 (en) 1997-10-23 1999-04-29 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
CA2388736A1 (en) 1999-10-22 2001-04-26 Washington University Oligodendrocyte cell cultures and methods for their preparation and use
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
WO2001068815A1 (en) 2000-03-14 2001-09-20 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
US20030223972A1 (en) 2002-02-15 2003-12-04 Goldman Steven A. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
US20050101014A1 (en) 2002-07-11 2005-05-12 Keirstead Hans S. Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US20050031598A1 (en) 2002-12-10 2005-02-10 Shulamit Levenberg Engineering three-dimensional tissue structures using differentiating embryonic stem cells
ES2569780T3 (es) 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
WO2006055685A2 (en) 2004-11-17 2006-05-26 Neuralstem, Inc. Transplantation of human neural cells for treatment of neurodegenerative conditions
US8709797B2 (en) 2006-06-20 2014-04-29 Cook General Biotechnology Llc Systems and methods for cryopreservation of cells
EP2139497B1 (en) 2007-04-13 2013-11-06 Stemnion, INC. Methods for treating nervous system injury and disease
KR100941036B1 (ko) 2007-10-05 2010-02-05 고려대학교 산학협력단 인간 배아줄기세포로부터 척수신경계 희소돌기 아교세포생산을 위한 삼단계 분화기법
WO2009057111A2 (en) 2007-10-29 2009-05-07 Hadasit Medical Research Services & Development Limited Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
US8227247B2 (en) 2007-12-20 2012-07-24 Wisconsin Alumni Research Foundation Method of generating myelinating oligodendrocytes
CN101939362A (zh) 2008-01-30 2011-01-05 杰龙公司 用于培养干细胞衍生的少突胶质细胞前体细胞的合成表面
US9709553B2 (en) 2008-05-08 2017-07-18 University Of Rochester Treating myelin diseases with optimized cell preparations
EP2283115A1 (en) 2008-05-09 2011-02-16 The University Court Of The University Of Glasgow Materials and methods relating to cell based therapies
CN102325878A (zh) 2008-12-23 2012-01-18 斯特姆塞尔思加利福尼亚有限公司 少突胶质前体细胞的靶向细胞群及制备与使用方法
CA2766164A1 (en) 2009-06-25 2010-12-29 Geron Corporation Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes
EP2499241B8 (en) 2009-11-10 2018-02-21 The J. David Gladstone Institutes Methods of generating neural stem cells
CN102160546B (zh) 2010-02-24 2016-01-20 库克通用生物科技有限责任公司 冷冻保存细胞的系统和方法
WO2012021818A2 (en) 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use
US9193951B2 (en) 2010-10-26 2015-11-24 Case Western Reserve University Differentiation method for production of glial cell populations
KR101921350B1 (ko) 2010-12-17 2018-11-22 바이오라미나 에이비 인간 다능성 줄기세포를 유지하기 위한 시스템
CN109749996A (zh) 2011-01-12 2019-05-14 城户常雄 获得和维持纯化或富集的哺乳动物神经干细胞群和/或神经祖细胞群的培养方法
JP6204976B2 (ja) 2012-05-16 2017-09-27 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 多能性幹細胞由来の細胞培養物からニューロンを単離するための細胞表面特性
EP3766962B1 (en) 2013-02-06 2025-10-22 University of Rochester Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
US10160950B2 (en) * 2013-03-01 2018-12-25 Wisconsin Alumni Research Foundation Methods of maintaining, expanding and differentiating neuronal subtype specific progenitors
CA2906815A1 (en) 2013-03-15 2014-09-18 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
WO2015088625A2 (en) 2013-09-25 2015-06-18 Case Western Reserve University Compounds and methods of promoting myelination
JP6873705B2 (ja) 2014-05-22 2021-05-19 ニューヨーク ステム セル ファウンデーション インコーポレイテッド 多能性幹細胞由来の機能性オリゴデンドロサイト、ならびにその作製方法及び使用方法
CN113564123B (zh) * 2014-10-24 2024-11-15 住友制药株式会社 神经组织的制备方法
CN105624116B (zh) * 2014-11-07 2020-04-07 中国科学院上海生命科学研究院 利用多能干细胞制备神经前体细胞的方法
WO2016103269A1 (en) 2014-12-23 2016-06-30 Ramot At Tel-Aviv University Ltd. Populations of neural progenitor cells and methods of producing and using same
US10286009B2 (en) 2015-05-16 2019-05-14 Asterias Biotherapeutics, Inc. Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
CA3019514A1 (en) 2016-03-30 2017-10-05 Asterias Biotherapeutics, Inc. Oligodendrocyte progenitor cell compositions
AU2020210757B2 (en) 2019-01-23 2026-04-16 Asterias Biotherapeutics, Inc. Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006517084A (ja) 2002-07-16 2006-07-20 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 胚性幹細胞の分化を誘導する方法及びその用途
JP2010536357A (ja) 2007-08-20 2010-12-02 ユニヴァルシテ リブレ デ ブリュッセル 多能性幹細胞からのニューロン細胞の生成
JP2017511153A (ja) 2014-03-21 2017-04-20 セルラー ダイナミクス インターナショナル， インコーポレイテッド 中脳ドーパミン作動性ニューロンの生産およびその使用方法
WO2017132596A1 (en) 2016-01-27 2017-08-03 Memorial Sloan-Kettering Cancer Center Differentiation of cortical neurons from human pluripotent stem cells
WO2020061371A2 (en) 2018-09-19 2020-03-26 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Develop. Neurobiol.，2012年，Vol.72，pp.1471-1481
Methods，2018年，Vol.133，pp.65-80
Stem Cell Res. Ther.，2018年，Vol.9，67 (pp.1-13)
Stem Cells Development，2014年，Vol.23, No.1，pp.5-15

Also Published As

Publication number Publication date
JP2022520722A (ja) 2022-04-01
US20260167925A1 (en) 2026-06-18
KR20210121112A (ko) 2021-10-07
KR102910994B1 (ko) 2026-01-12
CN113474451A (zh) 2021-10-01
EP3914264A4 (en) 2022-11-23
US11603518B2 (en) 2023-03-14
WO2020154533A1 (en) 2020-07-30
CA3127213A1 (en) 2020-07-30
JP2024096785A (ja) 2024-07-17
US20200231932A1 (en) 2020-07-23
SG11202107732XA (en) 2021-08-30
AU2020210757A1 (en) 2021-08-05
US20230139899A1 (en) 2023-05-04
EP3914264A1 (en) 2021-12-01
KR20260020476A (ko) 2026-02-11
CN113474451B (zh) 2025-06-10
AU2026204574A1 (en) 2026-07-02
AU2020210757B2 (en) 2026-04-16
CN120060141A (zh) 2025-05-30

Similar Documents

Publication Publication Date Title
KR102910994B1 (ko) 인간 만능 줄기 세포로부터의 배측-유래된 희소돌기아교세포 전구 세포
JP7569089B2 (ja) 動的懸濁培養において多能性幹細胞を分化させるための方法
JP2008099662A (ja) 幹細胞の培養方法
CA3182115A1 (en) Methods for differentiating stem cells into dopaminergic progenitor cells
JP2022508444A (ja) 無担体３ｄ球体浮遊培養における網膜ニューロン生成のための方法および組成物
JP2022520722A5 (cg-RX-API-DMAC7.html)
HK40124763A (en) Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
HK40061262B (en) Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
HK40125770A (en) Methods for differentiating pluripotent stem cells in dynamic suspension culture
HK40061262A (zh) 来自人多能干细胞的背源性少突胶质祖细胞
JP2024512385A (ja) 乏突起膠細胞前駆細胞を生成する方法及びその使用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221021

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240126

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240126

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240307

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240404

R150 Certificate of patent or registration of utility model

Ref document number: 7469317

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150